The developability of heteroaromatic and heteroaliphatic rings - do some have a better pedigree as potential drug molecules than others?

被引:154
作者
Ritchie, Timothy J. [1 ]
Macdonald, Simon J. F. [2 ]
Peace, Simon [2 ]
Pickett, Stephen D. [3 ]
Luscombe, Christopher N. [3 ]
机构
[1] TJR Chem, I-21020 Ranco, VA, Italy
[2] GlaxoSmithKline Med Res Ctr, Resp CEDD, Stevenage SG1 2NY, Herts, England
[3] GlaxoSmithKline Med Res Ctr, Computat & Struct Chem, Stevenage SG1 2NY, Herts, England
关键词
MEDICINAL CHEMISTRY; DISCOVERY; LIPOPHILICITY; PAIRS; SET;
D O I
10.1039/c2md20111a
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aqueous solubility, protein binding and CYP450 inhibition data for compounds containing a variety of heteroaromatic and heteroaliphatic rings were analysed and compared to determine which ring types fared best and worst in these developability screens. The results suggest that certain heterorings are generally more developable than others: how this information may be used and some caveats to be borne in mind are discussed.
引用
收藏
页码:1062 / 1069
页数:8
相关论文
共 25 条
[1]   Oxadiazoles in Medicinal Chemistry [J].
Bostrom, Jonas ;
Hogner, Anders ;
Llinas, Antonio ;
Wellner, Eric ;
Plowright, Alleyn T. .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (05) :1817-1830
[2]   Biotransformation reactions of five-membered aromatic heterocyclic rings [J].
Dalvie, DK ;
Kalgutkar, AS ;
Khojasteh-Bakht, SC ;
Obach, RS ;
O'Donnell, JP .
CHEMICAL RESEARCH IN TOXICOLOGY, 2002, 15 (03) :269-299
[3]   Generation of a set of simple, interpretable ADMET rules of thumb [J].
Gleeson, M. Paul .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (04) :817-834
[4]   Matched Molecular Pairs as a Medicinal Chemistry Tool [J].
Griffen, Ed ;
Leach, Andrew G. ;
Robb, Graeme R. ;
Warner, Daniel J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (22) :7739-7750
[5]   Molecular obesity, potency and other addictions in drug discovery [J].
Hann, Michael M. .
MEDCHEMCOMM, 2011, 2 (05) :349-355
[6]   AROMATIC SUBSTITUENT CONSTANTS FOR STRUCTURE-ACTIVITY CORRELATIONS [J].
HANSCH, C ;
LEO, A ;
UNGER, SH ;
KIM, KH ;
NIKAITANI, D ;
LIEN, EJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (11) :1207-1216
[7]   The reduced graph descriptor in virtual screening and data-driven clustering of high-throughput screening data [J].
Harper, G ;
Bravi, GS ;
Pickett, SD ;
Hussain, J ;
Green, DVS .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2004, 44 (06) :2145-2156
[8]   Medicinal chemistry of hERG optimizations: Highlights and hang-ups [J].
Jamieson, Craig ;
Moir, Elizabeth M. ;
Rankovic, Zoran ;
Wishart, Grant .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (17) :5029-5046
[9]   A comprehensive listing of bioactivation pathways of organic functional groups [J].
Kalgutkar, AS ;
Gardner, I ;
Obach, RS ;
Shaffer, CL ;
Callegari, E ;
Henne, KR ;
Mutlib, AE ;
Dalvie, DK ;
Lee, JS ;
Nakai, Y ;
O'Donnell, JP ;
Boer, J ;
Harriman, SP .
CURRENT DRUG METABOLISM, 2005, 6 (03) :161-225
[10]   Extraction of tacit knowledge from large ADME data sets via pairwise analysis [J].
Keefer, Christopher E. ;
Chang, George ;
Kauffman, Gregory W. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (12) :3739-3749